Abera Bioscience AB (NGM:ABERA)
Sweden
· Delayed Price · Currency is SEK 7.30
-0.85 (-10.43%)
At close: May 13, 2025
Abera Bioscience AB Revenue
Abera Bioscience AB had revenue of 3.57M SEK in the quarter ending March 31, 2025, with 57.44% growth. This brings the company's revenue in the last twelve months to 16.15M, up 236.95% year-over-year. In the year 2024, Abera Bioscience AB had annual revenue of 14.85M with 488.13% growth.
Revenue (ttm)
16.15M
Revenue Growth
+236.95%
P/S Ratio
7.51
Revenue / Employee
2.69M
Employees
6
Market Cap
121.28M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 104.49B |
| Atlas Copco AB | 176.63B |
| AB Volvo | 517.43B |
| EQT AB | 30.39B |
| ASSA ABLOY AB | 152.90B |
| Skandinaviska Enskilda Banken AB | 79.55B |
| Swedbank AB | 73.90B |
| Telefonaktiebolaget LM Ericsson | 249.58B |